Literature DB >> 8494894

Characterization of recombinant human farnesyl-protein transferase: cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases.

C A Omer1, A M Kral, R E Diehl, G C Prendergast, S Powers, C M Allen, J B Gibbs, N E Kohl.   

Abstract

We have isolated cDNAs encoding the alpha and beta subunits of human farnesyl-protein transferase (FPTase). The proteins encoded by these two cDNAs are 93-95% identical to the corresponding subunits of bovine and rat FPTase and show regions of homology with proteins encoded by Saccharomyces cerevisiae prenyl-protein transferase genes. Human FPTase expressed in Escherichia coli from a translationally coupled operon had kinetic properties similar to those of FPTase isolated from bovine brain. Examination of farnesyl diphosphate binding indicated that while neither individual subunit was capable of isoprenoid binding, a radiolabeled farnesyl diphosphate analog could be specifically photo-cross-linked to the beta subunit of FPTase holoenzyme. To further analyze subunit structure-function and to detect functional similarities with yeast prenyl-protein transferases (FPTase and two geranylgeranyl-protein transferases), amino acid changes homologous to those found in mutant yeast prenyl-protein transferase subunits were made in the subunits of human FPTase. Substitutions in either the alpha or beta subunits that decrease the activity of yeast prenyl-protein transferases were also observed to impair human FPTase. Kinetic analyses showed that these mutant human FPTases have Km and kcat values that are altered with respect to wild-type human FPTase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8494894     DOI: 10.1021/bi00070a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase.

Authors:  Richard T Eastman; John White; Oliver Hucke; Kohei Yokoyama; Christophe L M J Verlinde; Michael A Hast; Lorena S Beese; Michael H Gelb; Pradipsinh K Rathod; Wesley C Van Voorhis
Journal:  Mol Biochem Parasitol       Date:  2006-12-22       Impact factor: 1.759

2.  Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities.

Authors:  James L Hougland; Katherine A Hicks; Heather L Hartman; Rebekah A Kelly; Terry J Watt; Carol A Fierke
Journal:  J Mol Biol       Date:  2009-10-28       Impact factor: 5.469

3.  Expansion of protein farnesyltransferase specificity using "tunable" active site interactions: development of bioengineered prenylation pathways.

Authors:  James L Hougland; Soumyashree A Gangopadhyay; Carol A Fierke
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

4.  Mutant farnesyltransferase beta subunit of Saccharomyces cerevisiae that can substitute for geranylgeranyltransferase type I beta subunit.

Authors:  H Mitsuzawa; K Esson; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  A photoactive isoprenoid diphosphate analogue containing a stable phosphonate linkage: synthesis and biochemical studies with prenyltransferases.

Authors:  Amanda J DeGraw; Zongbao Zhao; Corey L Strickland; A Huma Taban; John Hsieh; Michael Jefferies; Wenshuang Xie; David K Shintani; Colleen M McMahan; Katrina Cornish; Mark D Distefano
Journal:  J Org Chem       Date:  2007-05-04       Impact factor: 4.354

6.  Actinoplanic acids A and B as novel inhibitors of farnesyl-protein transferase.

Authors:  K C Silverman; C Cascales; O Genilloud; J M Sigmund; S E Gartner; G E Koch; M M Gagliardi; B K Heimbuch; M Nallin-Omstead; M Sanchez
Journal:  Appl Microbiol Biotechnol       Date:  1995 Aug-Sep       Impact factor: 4.813

7.  NMR studies of novel inhibitors bound to farnesyl-protein transferase.

Authors:  K S Koblan; J C Culberson; S J Desolms; E A Giuliani; S D Mosser; C A Omer; S M Pitzenberger; M J Bogusky
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

8.  Synthesis, properties, and applications of diazotrifluropropanoyl-containing photoactive analogs of farnesyl diphosphate containing modified linkages for enhanced stability.

Authors:  Marisa L Hovlid; Rebecca L Edelstein; Olivier Henry; Joshua Ochocki; Amanda DeGraw; Stepan Lenevich; Trista Talbot; Victor G Young; Alan W Hruza; Fernando Lopez-Gallego; Nicholas P Labello; Corey L Strickland; Claudia Schmidt-Dannert; Mark D Distefano
Journal:  Chem Biol Drug Des       Date:  2010-01       Impact factor: 2.817

9.  A versatile photoactivatable probe designed to label the diphosphate binding site of farnesyl diphosphate utilizing enzymes.

Authors:  Olivier Henry; Fernando Lopez-Gallego; Sean A Agger; Claudia Schmidt-Dannert; Stephanie Sen; David Shintani; Katrina Cornish; Mark D Distefano
Journal:  Bioorg Med Chem       Date:  2009-04-22       Impact factor: 3.641

Review 10.  Farnesyltransferase inhibitors and anti-Ras therapy.

Authors:  J B Gibbs; N E Kohl; K S Koblan; C A Omer; L Sepp-Lorenzino; N Rosen; N J Anthony; M W Conner; S J deSolms; T M Williams; S L Graham; G D Hartman; A Oliff
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.